News Release Archive

Latest news about insulin supplies in the event that the UK leaves the EU without a deal

Insulin

House of Commons – Written Answers – Department of Health & Social Care

Answered on: Monday 9 September 2019

Department of Health & Social Care

Frank Field (Birkenhead): To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that an adequate supply of insulin is available in the event that the UK leaves the EU without a deal. [284604]

Chris Skidmore (Kingswood): As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that we should be fully prepared for leaving on 31 October, and that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the EU on 31 October.

The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines and medical products, including insulin, to the whole of the United Kingdom and its Crown Dependencies.

On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.

Further details can be found at the following link:
https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans